Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Isabel Villaoslada"'
Autor:
Marta Mascaraque, Sarah Courtois, Alba Royo-García, David Barneda, Andrei M. Stoian, Isabel Villaoslada, Pilar Espiau-Romera, Ansooya Bokil, Andrés Cano-Galiano, Petra Jagust, Christopher Heeschen, Patricia Sancho
Publikováno v:
Journal of Translational Medicine, Vol 22, Iss 1, Pp 1-18 (2024)
Abstract Background We have previously demonstrated the significant reliance of pancreatic Cancer Stem Cells (PaCSCs) on mitochondrial oxidative phosphorylation (OXPHOS), which enables versatile substrate utilization, including fatty acids (FAs). Not
Externí odkaz:
https://doaj.org/article/b76235b5122646e48554bd73d51d1a71
Autor:
Pilar Blanco Lobo, Paloma Guisado-Hernández, Isabel Villaoslada, Beatriz de Felipe, Carmen Carreras, Hector Rodriguez, Begoña Carazo-Gallego, Ana Méndez-Echevarria, José Manuel Lucena, Pilar Ortiz Aljaro, María José Castro, José Francisco Noguera-Uclés, Joshua D. Milner, Katelyn McCann, Ofer Zimmerman, Alexandra F. Freeman, Michail S. Lionakis, Steven M. Holland, Olaf Neth, Peter Olbrich
Publikováno v:
JOURNAL OF CLINICAL IMMUNOLOGY
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
[Purpose] STAT1 gain-of-function (GOF) and dominant-negative (DN) STAT3 syndromes share clinical manifestations including infectious and inflammatory manifestations. Targeted treatment with Janus-kinase (JAK) inhibitors shows promising results in tre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::19ddba73a8a5b8fb0a8970e12e82b3de
https://doi.org/10.1007/s10875-022-01273-x
https://doi.org/10.1007/s10875-022-01273-x
Autor:
Beatriz Parejo-Alonso, Alba Royo-García, Pilar Espiau-Romera, Sarah Courtois, Álvaro Curiel-García, Sladjana Zagorac, Isabel Villaoslada, Kenneth P. Olive, Christopher Heeschen, Patricia Sancho
Publikováno v:
Biomedicinepharmacotherapy = Biomedecinepharmacotherapie. 158
Pancreatic ductal adenocarcinoma (PDAC) is an extremely aggressive disease characterized by its metastatic potential and chemoresistance. These traits are partially attributable to the highly tumorigenic pancreatic cancer stem cells (PaCSCs). Interes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5c0e45b6a657ad50e13eb65b2ca29520
https://pubmed.ncbi.nlm.nih.gov/36571997
https://pubmed.ncbi.nlm.nih.gov/36571997
Autor:
Beatriz Parejo-Alonso, Alba Royo-García, Pilar Espiau-Romera, Sarah Courtois, Álvaro Curiel-García, Sladjana Zagorac, Isabel Villaoslada, Kenneth P. Olive, Christopher Heeschen, Patricia Sancho
Pancreatic ductal adenocarcinoma (PDAC) is an extremely aggressive disease characterized by its metastatic potential and chemoresistance. These traits are partially attributable to the highly tumorigenic pancreatic cancer stem cells (PaCSCs). Interes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f8a4582a0511c6ef69a7fd6500ca85d4
https://doi.org/10.1101/2022.08.29.505637
https://doi.org/10.1101/2022.08.29.505637
Autor:
Anne Puel, Paloma Guisado Hernández, José Manuel Lucena, Wei-Te Lei, Peter Olbrich, Pilar Blanco Lobo, Olaf Neth, Beatriz de Felipe, Jean-Laurent Casanova, Isabel Villaoslada, Simon J. Pelham
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f138b50e6e15ac305c3ab3d4368805b4
https://doi.org/10.1111/pai.13603/v2/response1
https://doi.org/10.1111/pai.13603/v2/response1
Autor:
Guillermo Martín Gutierrez, Beatriz de Felipe, Paloma Guisado Hernández, María Isabel Sánchez Codez, Peter Olbrich, José Manuel Lucena, María José Castro, Alicia Gutiérrez Valencia, Isabel Villaoslada, Mirella Gaboli, Olaf Neth, Pilar Blanco Lobo
Publikováno v:
Digital.CSIC. Repositorio Institucional del CSIC
instname
Journal of Clinical Immunology
instname
Journal of Clinical Immunology
Recently, 94 inborn errors of immunity (IEI) patients suffering from COVID-19 have been described, overall demonstrating a mild phenotype [1] although more severe disease manifestations have been suggested for patients with alterations in the interfe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e9c7b186dd18843a80a193af2b47325
https://link.springer.com/content/pdf/10.1007/s10875-021-01081-9.pdf
https://link.springer.com/content/pdf/10.1007/s10875-021-01081-9.pdf
Autor:
Anne Puel, Jean-Laurent Casanova, Simon J. Pelham, Isabel Villaoslada, Paloma Guisado Hernández, Wei-Te Lei, Olaf Neth, Peter Olbrich, José Manuel Lucena, Beatriz de Felipe, Pilar Blanco Lobo
Publikováno v:
Digital.CSIC. Repositorio Institucional del CSIC
instname
instname
[Background] Inherited chronic mucocutaneous candidiasis (CMC) is often caused by inborn errors of immunity, impairing the response to, or the production of IL-17A and IL-17F. About half of the cases carry STAT1 gain-of-function (GOF) mutations. Only
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8c6df16bc3c2dd1b9f50e5568ca1f2fa
http://hdl.handle.net/10261/269406
http://hdl.handle.net/10261/269406